H79TI088291
Project Grant
Overview
Grant Description
ODYSSEY HOUSE LOUISIANA HEP C FREE PROGRAM - ODYSSEY HOUSE LOUISIANA, INC. (OHL) WILL IMPLEMENT A COMPREHENSIVE HCV ELIMINATION PROGRAM (HEP C FREE) DESIGNED TO SERVE INDIVIDUALS AT HIGHEST RISK FOR HEPATITIS C (HCV), INCLUDING THOSE EXPERIENCING HOMELESSNESS, SUBSTANCE USE DISORDER (SUD), SERIOUS MENTAL ILLNESS (SMI), AND CO-OCCURRING CONDITIONS. BUILDING UPON ITS EXISTING CONTINUUM OF CARE AND SYNDEMIC PUBLIC HEALTH MODEL, OHL WILL EMBED SAME-DAY HCV SCREENING, DIAGNOSIS, AND TREATMENT INITIATION ACROSS ALL ITS SERVICE SETTINGS—INCLUDING SHELTERS, TREATMENT PROGRAMS, AND PRIMARY CARE—WHILE STRENGTHENING OUTREACH, EDUCATION, AND CARE COORDINATION EFFORTS THROUGHOUT THE COMMUNITY. OHL ANTICIPATES REACHING 1,000 INDIVIDUALS ANNUALLY THROUGH OUTREACH, TRAINING AND ENGAGEMENT EFFORTS AND TO PROVIDE SAME-DAY HCV SCREENING, TESTING AND TREATMENT INITIATION TO 300 INDIVIDUALS PER YEAR, ULTIMATELY CURING THESE INDIVIDUALS OF HCV. OHL’S OUTREACH AND ENGAGEMENT STRATEGY WILL FOCUS ON MEETING PEOPLE WHERE THEY ARE, CONDUCTING STREET-LEVEL OUTREACH IN ENCAMPMENTS, PARKS, SHELTERS, AND OVERDOSE “HOTSPOT” AREAS. THROUGH ITS IPREVENT OUTREACH TEAM, OHL WILL PROVIDE ONSITE RAPID HCV/HIV SCREENING, RISK ASSESSMENTS, AND HARM REDUCTION S RESOURCE DISTRIBUTION SUCH AS NALOXONE, FENTANYL TEST STRIPS, AND SAFER SEX KITS. INDIVIDUALS IDENTIFIED AT-RISK WILL RECEIVE WARM HANDOFFS TO SAME-DAY APPROPRIATE CARE. IN ADDITION, OHL WILL OFFER EDUCATIONAL TRAININGS FOR COMMUNITY MEMBERS AND PROVIDERS ON INFECTIOUS DISEASES, HARM REDUCTION, AND STIGMA REDUCTION, WITH PRE- AND POST-ASSESSMENTS TO EVALUATE EFFECTIVENESS. TO RAISE COMMUNITY AWARENESS, OHL WILL IMPLEMENT SOCIAL MEDIA CAMPAIGNS FOCUSED ON SUBSTANCE USE, MENTAL HEALTH, HCV, HIV, AND EMERGING DRUG THREATS. CAMPAIGNS SUCH AS “HCV FREE ME!” WILL USE STORYTELLING TO DESTIGMATIZE TESTING AND PROMOTE TREATMENT ACCESS. MESSAGING WILL BE SHARED ACROSS MULTIPLE SOCIAL MEDIA PLATFORMS WITH ADDITIONAL PHYSICAL MARKETING PLACED ON BILLBOARDS AND PUBLIC TRANSIT LOCATIONS TO REACH BROADER AUDIENCES IN THE NEW ORLEANS AREA. COALITION BUILDING WILL PLAY A CENTRAL ROLE IN THE PROGRAM. OHL WILL MAINTAIN AND EXPAND EXISTING PARTNERSHIPS THROUGH A SHARED SERVICE DIRECTORY, FACILITATE QUARTERLY COALITION MEETINGS, AND CO-HOSTED OUTREACH EVENT TO ENSURE A COORDINATED RESPONSE TO OVERLAPPING CRISES SUCH AS HCV, HOMELESSNESS, SUD, AND SMI. A CENTRAL INNOVATION OF THIS PROGRAM IS OHL’S CAPACITY TO PROVIDE SAME-DAY, ON-SITE HCV RNA TESTING AND TREATMENT INITIATION. INDIVIDUALS WITH REACTIVE RAPID TESTS WILL BE TRANSPORTED VIA UBER HEALTH TO ONE OF OHL’S FEDERALLY QUALIFIED HEALTH CENTER (OHCHC) LOCATIONS FOR CONFIRMATORY TESTING AND SAME-DAY PRESCRIPTION OF DIRECT-ACTING ANTIVIRALS (DAAS). OHL’S ON-SITE 340B PHARMACY WILL DISPENSE DAAS IMMEDIATELY OR PROVIDE FREE DELIVERY TO CLIENTS WITHOUT TRANSPORTATION OR STABLE HOUSING. PROGRAM STAFF WILL FOLLOW PROGRAM PARTICIPANTS CARE THROUGH SUSTAINED VIROLOGIC RESPONSE AT 12 WEEKS ENSURING CURE FROM THE INFECTION. THE PROGRAM WILL ENSURE SUSTAINED TREATMENT ENGAGEMENT BY ASSIGNING EACH PARTICIPANT WHO TESTS REACTIVE FOR HCV TO A CASE MANAGER WITH LIVED EXPERIENCE. THESE CASE MANAGERS WILL HELP CLIENTS NAVIGATE MEDICAL, MENTAL HEALTH, AND SOCIAL SERVICE SYSTEMS WHILE PROVIDING PEER SUPPORT, ADVOCACY, AND INDIVIDUALIZED CARE PLANNING. OHL’S CASE MANAGEMENT APPROACH WILL FOCUS ON OVERCOMING SYSTEMIC BARRIERS SUCH AS LACK OF ID, TRANSPORTATION, OR INSURANCE, AND MAINTAINING CONTINUOUS ENGAGEMENT THROUGH FOLLOW-UP, GOAL-SETTING, AND CRISIS INTERVENTION. ANNUAL PUBLIC REPORTS WILL SUMMARIZE PROGRAM IMPACT, IDENTIFY CHALLENGES, AND SHARE BEST PRACTICES. OHL WILL ALSO PARTICIPATE IN ALL REQUIRED SAMHSA LEARNING COLLABORATIVES AND EVALUATIONS THROUGHOUT THE THREE-YEAR PROJECT PERIOD. WITH OVER 13,500 UNDUPLICATED INDIVIDUALS SERVED ANNUALLY THROUGH ITS CONTINUUM OF CARE, OHL IS UNIQUELY POSITIONED TO MAKE A SIGNIFICANT IMPACT ON HCV ELIMINATION EFFORTS IN NEW ORLEANS, PARTICULARLY AMONG MARGINALIZED INDIVIDUALS.
Awardee
Funding Goals
SAMHSA WAS GIVEN THE AUTHORITY TO ADDRESS PRIORITY SUBSTANCE ABUSE TREATMENT, PREVENTION AND MENTAL HEALTH NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE THROUGH ASSISTANCE (GRANTS AND COOPERATIVE AGREEMENTS) TO STATES, POLITICAL SUBDIVISIONS OF STATES, INDIAN TRIBES AND TRIBAL ORGANIZATIONS, AND OTHER PUBLIC OR NONPROFIT PRIVATE ENTITIES. UNDER THESE SECTIONS, CSAT, CMHS AND CSAP SEEK TO EXPAND THE AVAILABILITY OF EFFECTIVE SUBSTANCE ABUSE TREATMENT AND RECOVERY SERVICES AVAILABLE TO AMERICANS TO IMPROVE THE LIVES OF THOSE AFFECTED BY ALCOHOL AND DRUG ADDITIONS, AND TO REDUCE THE IMPACT OF ALCOHOL AND DRUG ABUSE ON INDIVIDUALS, FAMILIES, COMMUNITIES AND SOCIETIES AND TO ADDRESS PRIORITY MENTAL HEALTH NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE AND ASSIST CHILDREN IN DEALING WITH VIOLENCE AND TRAUMATIC EVENTS THROUGH BY FUNDING GRANT AND COOPERATIVE AGREEMENT PROJECTS. GRANTS AND COOPERATIVE AGREEMENTS MAY BE FOR (1) KNOWLEDGE AND DEVELOPMENT AND APPLICATION PROJECTS FOR TREATMENT AND REHABILITATION AND THE CONDUCT OR SUPPORT OF EVALUATIONS OF SUCH PROJECTS, (2) TRAINING AND TECHNICAL ASSISTANCE, (3) TARGETED CAPACITY RESPONSE PROGRAMS (4) SYSTEMS CHANGE GRANTS INCLUDING STATEWIDE FAMILY NETWORK GRANTS AND CLIENT-ORIENTED AND CONSUMER RUN SELF-HELP ACTIVITIES AND (5) PROGRAMS TO FOSTER HEALTH AND DEVELOPMENT OF CHILDREN, (6) COORDINATION AND INTEGRATION OF PRIMARY CARE SERVICES INTO PUBLICLY-FUNDED COMMUNITY MENTAL HEALTH CENTERS AND OTHER COMMUNITY-BASED BEHAVIORAL HEALTH SETTINGS
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New Orleans,
Louisiana
701193549
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 92% from $3,907,500 to $7,500,000.
Odyssey House Louisiana was awarded
HCV Free Program for High-Risk Individuals in New Orleans
Project Grant H79TI088291
worth $7,500,000
from the Division of Grants Management in September 2025 with work to be completed primarily in New Orleans Louisiana United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance.
The Project Grant was awarded through grant opportunity Hepatitis C Elimination Initiative Pilot.
Status
(Ongoing)
Last Modified 9/26/25
Period of Performance
9/30/25
Start Date
9/29/27
End Date
Funding Split
$7.5M
Federal Obligation
$0.0
Non-Federal Obligation
$7.5M
Total Obligated
Activity Timeline
Transaction History
Modifications to H79TI088291
Additional Detail
Award ID FAIN
H79TI088291
SAI Number
H79TI088291-3208655413
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75SAMH SAMHSA Division of Grants Management
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
NCJBFLNGCKM1
Awardee CAGE
37AR9
Performance District
LA-02
Senators
Bill Cassidy
John Kennedy
John Kennedy
Modified: 9/26/25